Leef Brands (LEEEF) Debt Ratio (2024 - 2026)

Leef Brands (LEEEF) posted Debt Ratio of 0.25 for Q1 2026, down 16.85% sequentially from 0.31 in Q4 2025.

Leef Brands (LEEEF) Debt Ratio (2024 - 2026) Analysis & Trends

Leef Brands has reported Debt Ratio for 3 years, with the latest figure at 0.25 in Q1 2026.

Quarterly Debt Ratio changed N/A year-over-year to 0.25 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.25 (changed N/A YoY) and the FY2025 annual result came in at 0.31, up 18.49% from the prior year.
Debt Ratio declined to 0.25 in Q1 2026 per LEEEF's latest filing, from 0.31 in the prior quarter.
Over five years, Debt Ratio peaked at 0.31 in Q4 2025 and troughed at 0.25 in Q1 2026.
A 3-year average of 0.27 and a median of 0.26 in 2024 frame the typical range for Debt Ratio.
The widest YoY moves for Debt Ratio: up 18.49% in 2025, down 18.49% in 2025.
Over 3 years, Debt Ratio stood at 0.26 in 2024, then rose by 18.49% to 0.31 in 2025, then fell by 16.85% to 0.25 in 2026.
According to Business Quant data, Debt Ratio over the past three periods registered 0.25, 0.31, and 0.26 for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-0.13
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	0.42
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	0.60
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	0.32
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	0.38
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	0.29
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	0.12
10	Leef Brands	59.45 Mn	54.50 Mn	2.41 Mn	0.20

Download Data